drugset / Trial / NCT02040116
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the impact of rapid infusion rituximab on the incidence of infusion-related reactions in patients with Autoimmune Diseases.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | — | — |